Severe H1N1-associated acute respiratory failure in immunocompromised children

Lama Elbahlawan1, Aditya H Gaur, Wayne Furman

  • 1Division of Critical Care Medicine, St. Jude Children's Research Hospital, Tennessee 38105-3678, USA. lama.elbahlawan@stjude.org

Pediatric Blood & Cancer
|February 8, 2011
PubMed

Insights

Critically ill children with cancer receiving chemotherapy who developed severe H1N1 influenza and acute respiratory failure (ARF) all survived with aggressive intensive care. Early detection of oseltamivir-resistant H1N1 is crucial for this vulnerable population.

Area of Science:

  • Pediatric Critical Care Medicine
  • Infectious Diseases
  • Pediatric Oncology

Background:

  • Severe pandemic influenza A (H1N1) infection poses a high mortality risk, particularly for children with malignancy.
  • Immunosuppression from chemotherapy or underlying disease increases H1N1-associated acute respiratory failure (ARF) risk in pediatric oncology patients.

Purpose of the Study:

  • To describe the clinical course and outcomes of critically ill pediatric oncology and hematology patients experiencing H1N1-associated ARF.
  • To evaluate the effectiveness of intensive care interventions in this high-risk group.

Main Methods:

  • Retrospective case series of five pediatric oncology/hematology patients admitted to the ICU with H1N1 infection and ARF during the 2009-2010 influenza season.
  • Detailed analysis of clinical course, ventilatory support, medical management, and patient outcomes.

Main Results:

  • All five patients, despite requiring mechanical ventilation and intensive supportive care (including high-frequency oscillatory ventilation and nitric oxide), survived to hospital discharge.
  • Oseltamivir resistance was noted in two patients, necessitating a switch to intravenous zanamivir.
  • Mean mechanical ventilation duration was 24 days and mean ICU stay was 37 days.

Conclusions:

  • Aggressive supportive care is vital for managing H1N1-related ARF in immunocompromised children with cancer.
  • Early identification and management of oseltamivir-resistant H1N1 infections are critical for favorable outcomes in this vulnerable pediatric population.
Abstract

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...